Dynavax Technologies Corp. (DVAX)
15.51
+0.03
(+0.19%)
USD |
NASDAQ |
Feb 04, 16:00
15.50
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Market Cap : 1.821B for Feb. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 293.70B |
| Amicus Therapeutics, Inc. | 4.403B |
| Agios Pharmaceuticals, Inc. | 1.615B |
| Hyperion DeFi, Inc. | 29.56M |
| Edgewise Therapeutics, Inc. | 3.014B |
Market Cap Related Metrics
| PS Ratio | 6.484 |
| Price to Book Value | 3.410 |
| Price to Free Cash Flow | 26.61 |
| Price | 15.51 |
| Earnings Yield | -2.46% |
| Operating PE Ratio | 205.32 |
| Normalized PE Ratio | 198.08 |